Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Research Articles, Cellular/Molecular

Direct Interaction of PP2A Phosphatase with GABAB Receptors Alters Functional Signaling

Xiaofan Li, Miho Terunuma, Tarek G. Deeb, Shari Wiseman, Menelas N. Pangalos, Angus C. Nairn, Stephen J. Moss and Paul A. Slesinger
Journal of Neuroscience 1 April 2020, 40 (14) 2808-2816; DOI: https://doi.org/10.1523/JNEUROSCI.2654-19.2020
Xiaofan Li
1Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York 10029,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miho Terunuma
4Division of Oral Biochemistry, Graduate School of Medical and Dental Sciences, Niigata University, 951-8514 Japan,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tarek G. Deeb
2Department of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tarek G. Deeb
Shari Wiseman
2Department of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Menelas N. Pangalos
5IMED Biotech Unit, AstraZeneca, Cambridge, CB4 0WG United Kingdom, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angus C. Nairn
6Department Psychiatry, Yale University School of Medicine, New Haven, Connecticut 065019
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Angus C. Nairn
Stephen J. Moss
2Department of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111,
3Department of Physiology, Pharmacology and Neuroscience, University College, London WC1E 6BT, United Kingdom,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul A. Slesinger
1Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York 10029,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul A. Slesinger
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Addictive drugs usurp the brain's intrinsic mechanism for reward, leading to compulsive and destructive behaviors. In the ventral tegmental area (VTA), the center of the brain's reward circuit, GABAergic neurons control the excitability of dopamine (DA) projection neurons and are the site of initial psychostimulant-dependent changes in signaling. Previous work established that cocaine/methamphetamine exposure increases protein phosphatase 2A (PP2A) activity, which dephosphorylates the GABABR2 subunit, promotes internalization of the GABAB receptor (GABABR) and leads to smaller GABABR-activated G-protein-gated inwardly rectifying potassium (GIRK) currents in VTA GABA neurons. How the actions of PP2A become selective for a particular signaling pathway is poorly understood. Here, we demonstrate that PP2A can associate directly with a short peptide sequence in the C terminal domain of the GABABR1 subunit, and that GABABRs and PP2A are in close proximity in rodent neurons (mouse/rat; mixed sexes). We show that this PP2A-GABABR interaction can be regulated by intracellular Ca2+. Finally, a peptide that potentially reduces recruitment of PP2A to GABABRs and thereby limits receptor dephosphorylation increases the magnitude of baclofen-induced GIRK currents. Thus, limiting PP2A-dependent dephosphorylation of GABABRs may be a useful strategy to increase receptor signaling for treating diseases.

SIGNIFICANCE STATEMENT Dysregulation of GABAB receptors (GABABRs) underlies altered neurotransmission in many neurological disorders. Protein phosphatase 2A (PP2A) is involved in dephosphorylating and subsequent internalization of GABABRs in models of addiction and depression. Here, we provide new evidence that PP2A B55 regulatory subunit interacts directly with a small region of the C-terminal domain of the GABABR1 subunit, and that this interaction is sensitive to intracellular Ca2+. We demonstrate that a short peptide corresponding to the PP2A interaction site on GABABR1 competes for PP2A binding, enhances phosphorylation GABABR2 S783, and affects functional signaling through GIRK channels. Our study highlights how targeting PP2A dependent dephosphorylation of GABABRs may provide a specific strategy to modulate GABABR signaling in disease conditions.

  • GABA(B)
  • GIRK
  • inhibition
  • phosphatase
  • PLA
  • trafficking

Introduction

GABAB receptors (GABABRs) are widely expressed in the nervous system and localized to extrasynaptic sites both pre- and postsynaptically. Activation GABABRs dampens neuronal activity through several parallel pathways, including activation of G protein-gated inwardly rectifying potassium (GIRK) channels and inhibition of voltage-gated calcium channels and adenylyl cyclases. GABABRs are obligatory heterodimers consisting of two structurally similar subunits, whereby the GABABR1 contains the ligand binding site, and GABABR2 contains binding sites for allosteric modulators and couples to G-proteins (Galvez et al., 2000, 2001). Surface expression of GABABRs is determined by multiple tightly regulated trafficking processes, including ER export, internalization, recycling and degradation (Benke et al., 2012). Abnormal expression and signaling of GABABRs has been associated with many psychiatric illnesses, including epilepsy, depression, anxiety and drug addiction (Bowery, 2006). Understanding the regulatory pathways of GABABR trafficking will help us devise ways to remedy GABABR signaling in disease conditions.

GABABRs undergo agonist-induced desensitization, as well as cross-desensitization induced by activation of other receptors. Desensitization involves relatively fast processes at the level of G-protein signaling and a slower process of receptor endocytosis (Raveh et al., 2015). GABABRs are known to undergo constitutive endocytosis, followed by either degradation or recycling back to the plasma membrane (Vargas et al., 2008). How cells differentially regulate these pathways during receptor desensitization remains unclear. Unlike other GPCRs, GABABR desensitization does not involve phosphorylation by G protein-coupled receptor kinases (GRKs). They are, however, phosphorylated by PKA, AMPK and CaMKII enzymes, with the former two stabilizing the receptor on the cell surface, and the latter promoting endocytosis and degradation (Couve et al., 2002; Kuramoto et al., 2007; Guetg et al., 2010; Zemoura et al., 2019).

We previously demonstrated that the phosphorylation status of Serine 783 (S783) on GABABR2 determines receptor fate during postendocytic sorting, whereby phosphorylation by AMPK promotes recycling, and dephosphorylation by protein phosphatase 2A (PP2A) leads to lysosomal degradation (Kuramoto et al., 2007; Terunuma et al., 2010). Importantly, AMPK and PP2A activities are ideally balanced at basal conditions. Ischemic injury or transient anoxia results in AMPK activation and enhance S783 phosphorylation on GABABRs, promoting GABABR signaling and neuronal survival (Kuramoto et al., 2007). In cortical neurons, sustained NMDAR activation leads to a transient activation of AMPK and a corresponding transient increase in S783 phosphorylation/surface GABABR expression, which is followed by a sustained decrease that is PP2A dependent (Terunuma et al., 2010). Whether PP2A directly dephosphorylates S783 is yet uncertain, but PP2A was pulled down by GABABR1 subunit (Terunuma et al., 2010), suggesting a possible direct interaction between the two.

PP2A-mediated regulation of GABABR-GIRK signaling has thus far been observed in multiple brain regions in response to various stimuli. A single injection of psychostimulant leads to sustained depression of GABABR-GIRK currents in VTA GABA neurons (Padgett et al., 2012). This effect can be abolished by acutely inhibiting PP2A, and is absent in mice with a S783A mutation (Padgett et al., 2012; Munoz et al., 2016), suggesting that PP2A exerts its influence by regulating S783 phosphorylation. Furthermore, in layer 5/6 pyramidal neurons of the prelimbic cortex, a PP2A-dependent suppression of GABABR-GIRK was observed following repeated cocaine exposure (Hearing et al., 2013). Acute foot shocks resulted in a decrease in GABABR-GIRK signaling in lateral habenula (LHb) neurons at 1 h after the shock but persists for at least 2 weeks. PP2A inhibition rescued GABABR-GIRK currents as well as depressive-like behavioral phenotypes following foot shock stress (Lecca et al., 2016).

Together, these studies point to PP2A as a potential target for regulating aberrant GABABR signaling. However, PP2A is a ubiquitous phosphatase with highly diversified families of B subunits (Sontag, 2001; Slupe et al., 2011) and specific targeting of PP2A-GABABR interaction remains an important puzzle to solve. In the current study, we examine how PP2A may be directed to the GABABR, and regulate phosphorylation of GABABRs and their signaling through GIRK channels.

Materials and Methods

GST pull-down experiments

GST fusion proteins containing C-terminal deletions of the GABABR1 subunit were prepared as described previously (Couve et al., 2001). Adult male mice (C57BL6) were killed, brains were dissected and then homogenized in pull down assay buffer (50 mm HEPES-NaOH, pH 7.2, 5 mm MgCl2, 150 mm NaCl, 10% glycerol, 0.2% Triton X-100, 50 mm NaF, 10 mm sodium pyrophosphate, 1 mm sodium orthovanadate, 0.1% phenylmethylsulfonyl fluoride, 10 μg/ml leupeptin, 10 μg/ml pepstatin A, 10 μg/ml antipain) using a sonicator. The homogenate was centrifuged at 150,000 rpm for 30 min at 4°C. Then, 500 μg of supernatant was mixed with 20 μg of the corresponding fusion proteins immobilized on glutathione Sepharose 4B beads (GE Life Sciences), and samples were rotated overnight at 4°C. Beads were washed twice in pull down assay buffer, twice in pull down assay buffer containing 500 mm NaCl, and twice in pull down assay buffer. Associated proteins were eluted in 40 μl of 2× sample buffer, separated by SDS-PAGE and transferred to nitrocellulose membrane for immunoblotting with antibodies for PP2A-B55 and PP2A-C. For pull-down, anti-PR55 (PP2A-B55) (clone 2G9; Millipore), anti-PP2Ac (BD Biosciences) and anti-GABABR1 (Santa Cruz Biotechnology) were used. All procedures and experiments using rodents were approved by the institutional animal care and use committees at Tufts University and Icahn School of Medicine at Mount Sinai.

Immunoprecipitation of native GABABRs in cultured cortical neurons

Cultured cortical neurons were prepared from E18 rat embryo as described previously (Terunuma et al., 2014) and were cultured in B27 containing Neurobasal media for 5 d at 37°C in a humidified incubator with 5% CO2. Neurons were then incubated with membrane-permeable TAT-R1-pep or scrambled peptides for 24 h at a concentration of 1 μm. Peptides were synthesized by New England peptide (www.newenglandpeptide.com) and were of >95% purity. The sequence of TAT-R1-pep was Biotin-GRKKRRQRRRPQGRQQLRSRRHPPT and TAT-scrambled was Biotin-GRKKRRQRRRPQGQPQRLRSPRHRT. Neurons were washed twice with PBS and lysed in Buffer A (20 mm Tris-HCl, pH 8.0, 150 mm NaCl, 5 mm EDTA, 1% Triton X-100, 10 mm NaF, 10 mm sodium pyrophosphate, 2 mm sodium orthovanadate, 0.1% phenylmethylsulfonyl fluoride, 10 μg/ml leupeptin, 10 μg/ml pepstatin A, 10 μg/ml antipain). Homogenates were centrifuged at 150,000 rpm for 30 min at 4°C, preabsorbed with 40 μl of protein A agarose (Sigma-Aldrich) for 1 h at 4°C, and precleared supernatants were incubated with 1 μg of nonimmune IgG or GABABR1 antibodies for 1 h at 4°C. Immune complexes were precipitated with 40 μl of protein A agarose overnight at 4°C, washed twice with Buffer A, twice with 500 mm NaCl containing Buffer A, and finally twice with Buffer A. Immunoprecipitated proteins were eluted in 40 μl of 2× sample buffer, boiled for 3 min, and analyzed by SDS-PAGE followed by immunoblotting. For IP, anti-PR55 (PP2A-B55) (clone 2G9; Millipore), anti-PP2Ac (BD Biosciences), anti-GABABR1 (Santa Cruz Biotechnology), and anti-GABABR2 p783 (Kuramoto et al., 2007) were used.

Mass spectrometry analysis

GABABR1 antibody or IgG were crosslinked onto protein A beads using 0.2 m triethanolamine, pH 8.2 (TEA), in the presence of 40 mm dimethyl pimelimidate (DMP) at room temperature for 30 min. After extensive washing, immunoprecipitation was performed as detailed above with mouse cortical neurons. Precipitated material was separated by SDS-PAGE, stained with Coomassie and bands of interest were excised and digested with trypsin (Nakamura et al., 2016). Samples were then subject to LC-MS/MS at the Yale/NIDA Neuroproteomic Center (https://medicine.yale.edu/keck/nida/general/mission.aspx). MS/MS spectra were searched against the mouse database (Uniprot) using the Sequest 28 analysis program. Peptide matches were considered true matches for ΔCN scores (delta correlation) > 0.2 and XCorr values (cross-correlation) >2, 2, 3, 4 for +1, +2, +3, +4 charged peptides respectively (Table 1). A particular protein would be considered present if at least five such high-quality peptides were detected. Proteins in detergent solubilized extracts of cortical neurons that were purified on control IgG were considered as nonspecific.

View this table:
  • View inline
  • View popup
Table 1.

Proteins immunoprecipitated with GABABRs from cultured cortical neurons

Cell culture and proximity ligation assay (PLA)

HEK293 cells were cultured in poly-d-lysine coated 12-well plates containing DMEM supplemented with 10% FBS, 1× Glutamax, 100 units/ml penicillin and 100 μg/ml streptomycin, at 37°C in a humidified air incubator with 5% CO2. Cells were transiently transfected using Lipofectamine 2000 with cDNA plasmids expressing GABABR1-eYFP, GABABR2 and GIRK2a. 24 h posttransfection cells were trypsinized and transferred to poly-d-lysine coated 8-well chamber slides and allowed to settle for 4–5 h. Cells were then fixed with 2% PFA in PBS for 7 min and permeabilized with PBS-0.1% Triton X-100 for 5 min before PLA assay.

For PLA with neurons, cerebral cortices of E18 C57B6/J mice were dissected in ice-cold HBSS supplemented with 10 mm HEPES and meninges were carefully removed. Cortical tissue was trimmed into pieces and incubated with 0.25% trypsin at 37°C for 15 min. Tissue was washed and triturated in culture media (Neurobasal Plus media supplemented with B-27 Plus, Glutamax and Pen-Strep; Invitrogen) using fire-polished thin glass pipettes. Cells were filtered through a 40 μm nylon cell strainer, counted and plated onto poly-d-lysine coated 8-well chamber slides (Falcon) at 5.7 × 105 cells/cm2. Half media exchanges were performed every 2 d and 1 μm AraC was applied on DIV2 to inhibit non-neuronal cell proliferation. PLA was performed on days in vitro (DIV) 6.

PLA was performed using Duolink in situ reagents (Sigma-Aldrich) following the manufacturer's instructions. Anti-rabbit PLUS and anti-mouse MINUS PLA probes and red detection reagents were used. For cortical neurons, MAP2 immunostaining was performed alongside PLA procedures. Slides were imaged with a digital camera (Canon) on a Zeiss fluorescence microscope with a 40× objective for HEK293 cells and 20× objective for cortical neurons. Exposure times, scope settings and lamp power were kept consistent for different experimental groups. PLA signals were quantified with particle analysis function in ImageJ after setting an appropriate threshold to filter out background signal. Cell numbers were counted manually. Antibodies used for PLA: anti-PP2A-C (Cell Signaling Technology #2038), anti-PP2A-B55 (Thermo Fisher MA5-15007), anti-GABABR1 (NeuroMab clone N93A/49), anti-GABABR2 (Thermo Fisher PA5-23720), anti-MAP2 (Abcam ab5392).

Electrophysiology in cultured cortical neurons

Rat cortical neurons were dissected as described above and plated onto glass coverslips at a density of 300,000 per 35 mm dish. Neurons were incubated in modified Neurobasal media (B27, Glutamax, glucose, Pen/Strep; Thermo Fisher) for 18–21 d before recordings. Recordings were performed in a bath solution containing (in mm) 140 NaCl, 2.5 KCl, 2.5 CaCl2, 2.5 MgCl2, 10 HEPES, 11 glucose, pH 7.4 by NaOH. AP5 (50 μm), DNQX (20 μm), picrotoxin (100 μm) and TTX (500 nm) were added to the bath to block NMDA, AMPA, GABAARs and NaV channels, respectively. Baclofen (10 μm) was used for GABABR activation. The patch-pipette solution contained the following (in mm): 135 K-gluconate, 10 KCl, 2 disodium-ATP, 2 Mg-ATP, 0.4 Na-GTP, 10 HEPES, pH 7.4 by KOH. All reagents were purchased from Tocris Biosciences. The synthetic peptides were added directly to the patch-pipette solution at a working concentration of 50 μm. R1-pep contained amino acids RQQLRSRRHPPT and scrambled contained amino acids QPRTPRHLSQRR. Recordings were performed at a holding potential of −50 mV and at 34°C. Series resistance was monitored every 3 min to ensure that the recordings were stable over time. All data were acquired using an Axopatch 200B amplifier and pClamp software (Molecular Devices).

Experimental design and statistical analyses

The design of experiments in this study involved either comparing two groups (e.g., PLA vs one control, experimental vs control peptide), or multiple groups (e.g., PLA vs multiple controls). Sexes were mixed for all experiments, except for males used in GST pull-down experiments. For statistical analyses of two groups, we used a ratio-paired or unpaired Student's t test (one or two-tailed). For statistical analyses of multiple groups, we used one-way ANOVA with Tukey post hoc test for significance (p-value) between groups, with the significance indicated in the text. All calculations and comparisons were determined in Prism software (GraphPad) and values reported as mean ± SEM or in scatter plots with mean indicated by solid bar.

Results

PP2A is a trimeric protein consisting of a structural A subunit, a catalytic C subunit, and a regulatory B subunit (Sontag, 2001; Slupe et al., 2011). Previously, we found that the PP2A C subunit associates with GABABRs and specifically the GABABR1 subunit in a pull-down experiment with GST-GABABR1 (Terunuma et al., 2010). Here we confirmed this interaction by mass spec analysis of proteins immunoprecipitated from cortical neurons with GABABR1 antibody. We detected both the PP2A-Cα subunit and B55α subunit in precipitated material using the GABABR1 antibody, but not control IgG (Table 1). Next we sought to identify the amino acid sequence on GABABR1 that mediates this protein-protein interaction. To do so, we exposed the cytoplasmic domain of the R1 subunit (amino-acids 857–961) expressed as a glutathione-S-transferase fusion protein (GST-R1) to detergent solubilized brain extracts (Fig. 1A,B). To assess recruitment of PP2A, we immunoblotted GST pulldown material with an antibody that recognizes the catalytic subunit (PP2A-C), a core component of this divergent family of phosphatases. PP2A-C was bound to GST-R1, but not to GST alone. The PP2A-B55 subunit was also detected, indicating binding to GST-R1 (Fig. 1C). To further delineate which amino acids support binding to PP2A, we used shorter fusion proteins encoding distinct regions of GABABR1 subunit cytoplasmic domain Δ1–Δ6 (Fig. 1B). Compared with GST-R1, Δ1 and Δ3 exhibited reduced binding to PP2A-C and PP2A-B55 from brain lysates, while Δ4 and Δ5 showed little or no binding (Fig. 1C,D). Together, these results suggest that residues 917–927 are important in mediating the binding of GABABR1 to PP2A (Fig. 1B–D). Consistent with this conclusion, Δ6, which contains residues 905–928, was the smallest region that retained some interaction with PP2A.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Identification of the PP2A binding site in GABABR1 C-terminal domain. A, Diagram shows binding of PP2A (consisting of A–C subunits) to the C-terminal domain of the GABABR1 subunit. B, Schematic of seven different GST-tagged C terminal GABABR1 constructs used to localize the region of R1 involved in binding to PP2A. Numbers indicate amino acid positions in the full-length GABABR1 subunit. C, Immunoblot of pull-down. GABABR1 fusion proteins or GST alone were exposed to mouse brain lysates and bound proteins were subject to immunoblotting with antibodies against B55 (PR55), and C subunits of PP2A. Control lane shows input of PP2A enzyme. Bottom gel shows equal loading of GST fusion proteins revealed by Coomassie Blue staining. D, Bar chart shows the levels of PP2A binding to the different GABABR1 fusion proteins determined after subtracting background binding to GST alone. Mean ± SEM is shown for three separate experiments.

To test whether the interaction between PP2A and GABABR occurs in a living cell, we performed an in situ proximity ligation assay (PLA) with HEK293 cells transfected with GABABR1 and GABABR2 subunits. PLA is a sensitive method that detects protein-protein interactions with single-molecule resolution (Weibrecht et al., 2010; Koos et al., 2014). The proximity of antibodies against two interacting proteins allows ligation of DNA strands conjugated to the antibodies, forming a circular DNA template. The circular DNA is then amplified by PCR, and detected by fluorescent DNA-binding probes (Fig. 2Ai). Thus, each fluorescent puncta corresponds to one protein–protein complex. We first tested for interaction between endogenous PP2A and transiently expressed GABABRs (Fig. 2A) in HEK293 cells. Antibodies against the PP2A catalytic subunit (PP2A-C) and GABABR1 C terminus (R1) revealed a strong PLA signal (quantified as puncta per cell) in HEK293 cells transfected with GABABR1 and GABABR2 (Fig. 2Aiii). eYFP fused to the GABABR1 subunit allowed detection of transfected cells. We also performed PLA in HEK293 cells cotransfected with GIRK2, a downstream effector of GABABR that has been demonstrated to coassemble with GABABRs (Kulik et al., 2006; Fowler et al., 2007; Fernández-Alacid et al., 2009; Ciruela et al., 2010). The presence of GIRK2, however, did not significantly increase the PLA signal between PP2A-C and GABABR1 (Fig. 2C). For negative control, we performed two types of experiments. In the first negative control, we omitted the primary antibody but used both PLA probes. For the second control, we omitted one secondary PLA probe. In both cases, we found significantly fewer puncta. (Fig. 2A–C). The PLA signal was significantly smaller (p < 0.0001), and may represent background due to nonspecific antibody/probe binding (Fig. 2Aiv–Av,B,C). In untransfected HEK cells, we also observed background levels of puncta (Fig. 2Avi,C). HEK293 cells are reported to express GABABR1 but not GABABR2 mRNA (Atwood et al., 2011). Without GABABR2, however, GABABR1 cannot traffic to the cell surface and is trapped in the endoplasmic reticulum (ER) due to an ER retention signal present in the C-terminal domain (Couve et al., 1998; Margeta-Mitrovic et al., 2000; Pagano et al., 2001). Whether the weak PLA signal we observed in untransfected cells could come from native GABABR1 in the ER remains unknown.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Interaction between PP2A and GABABR full-length proteins as detected by proximity ligation assay (PLA) in HEK293 cells. Ai, Schematic of the PLA reaction between PP2A (antibody against C subunit) and eYFP-tagged GABABR (antibody against GABABR1 C terminus). Aii–Avi, Representative PLA images of HEK293 cells for the indicated experimental conditions: HEK293 cells were transfected with the cDNAs indicated above each image, and primary antibodies used for PLA are indicated (bottom left). Green: eYFP signal indicating transfected cells. Red is the PLA signal; each red puncta represents a single PP2A-GABABR complex. Blue is DAPI staining. B, Scatter plot shows quantification of PLA signal from one representative experiment. Each data point represents analysis of one image containing 1–11 HEK cells. Presence or absence of primary antibodies and secondary probes (m, mouse; r, rabbit) are indicated below. Magenta bar indicates mean. ****p < 0.0001, one-way ANOVA with Tukey's post hoc test (F(5,53) = 70.76). C, Scatter plot of normalized PLA signal pooled from three independent experiments. Data points were normalized to the R1 + R2 + GIRK2a PLA condition (first column). UT, Untransfected. Magenta bar indicates mean (****p < 0.0001, one-way ANOVA with Tukey's post hoc test; F(6,182) = 134.5).

Having shown a positive PLA signal with transfected HEK293 cells, we investigated whether the close association of PP2A with GABABRs also occurs with natively expressed proteins in neurons. We probed for interaction between GABABR1 and PP2A-C subunit, as well as between GABABR1 and the PP2A regulatory B55 subunit, in cultures of mouse cortical neurons. As a positive control for the PLA we tested for interaction between GABABR1 and GABABR2. We detected robust PLA signals for all three conditions, whereas very few puncta were seen with negative controls (one primary antibody omitted) (Fig. 3A–D). The PLA signals were detected in both the soma and dendrites (marked by MAP2 immunostaining). The PLA signals quantified as puncta per cell were significantly higher than negative controls for association between PP2A-C subunit and GABABR1 (p < 0.0001), PP2A-B55α (p < 0.0001), and GABABR1 (p < 0.0001), as well as GABABR1 and GABABR2 subunits (Fig. 3D).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Evidence for interaction of endogenous PP2A and GABABR in cultured cortical neurons. A–C, Representative PLA images of cultured mouse cortical neurons (DIV 6) with the indicated primary antibodies. Top three panels (Ai, Bi, Ci) show PLA signal (red) between PP2A-C subunit and GABABR1, PP2A-B55 and GABABR1, and between GABABR1 and GABABR2 subunits. Bottom three panels (Aii, Bii, Cii) show corresponding negative controls where a primary antibody was omitted. Green is MAP2 immunostaining; red is PLA signal; blue is DAPI staining. D, Scatter plot showing quantification of PLA signal corresponding to A–C from one representative experiment. Each data point represents analysis of one image containing ∼80 neurons. Magenta bar indicates mean. ****p < 0.0001 using unpaired Student's two-tailed t test. E, F, Regulation of PP2A-C and GABABR1 interaction by intracellular Ca2+. E, Representative images of DIV 6 cortical neurons treated with vehicle (Ei) or the calcium ionophore A23187 (2 μm, Eii) for 30 min before PLA for PP2A-C and GABABR1. F, Scatter plot showing normalized PLA signal pooled from three independent experiments. Data points were normalized to the vehicle average for each experiment. Control group received vehicle treatment but the PP2A-C antibody was omitted. Red bar indicates group mean for three experiments (****p < 0.0001, one-way ANOVA with Tukey's post hoc test; F(2,81) = 167.8).

Next, we investigated whether the association between PP2A and GABABR is physiologically regulated. We showed previously that increases in intracellular Ca2+ level, which models elevated neuronal activity, can enhance phosphorylation of S783 on GABABR2 (Terunuma et al., 2010). A high Ca2+ level activates AMP-dependent protein kinase (AMPK), which has been shown to phosphorylate S783 (Kuramoto et al., 2007; Terunuma et al., 2010). We hypothesized that under high Ca2+ level there is a concomitant decrease in PP2A-mediated dephosphorylation of S783 and potentially a decrease in the PP2A-GABABR interaction. To test this hypothesis, we treated neurons with the Ca2+ ionophore A23187 (2 μm) for 30 min, a condition that led to increased S783 phosphorylation in cortical neurons (Terunuma et al., 2010). In A23187-treated cells, we observed a significant decrease in the PLA signal for PP2A-C and GABABR1, compared with vehicle-treated neurons (Fig. 3E,F). Together, the PLA studies demonstrate that PP2A can associate with full-length GABABRs in different cell types, and that it is a dynamic interaction regulated by intracellular Ca2+.

If the direct association of PP2A with the GABABR is important for dephosphorylating p-S783, then we hypothesized that a R1 peptide that competes for PP2A binding might reduce the dephosphorylation, and therefore increase p-S783 (Terunuma et al., 2010). To test this hypothesis, we designed a new R1 peptide (TAT-R1-pep) that contains a TAT sequence (Green and Loewenstein, 1988) for crossing the plasma membrane and examined the effect in cultures of cortical neurons. TAT-R1-pep which competes for binding of PP2A to native GABABR1 reduced the amount of both PP2A B and C subunits that associates with GABABR1 in coimmunoprecipitation experiments (Fig. 4A). In addition, TAT-R1-pep significantly increased the level of S783 phosphorylation on the R2 subunit suggesting that interaction of PP2A with the C terminus of GABABR1 helps to regulate the phosphorylation state of S783 in GABABR2 (Fig. 1A).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

PP2A binding to GABABR1 modulates the level of phosphorylation at S783 in GABABR2 subunit. A, Coimmunoprecipitation (co-IP) of GABABR1 and PP2A from cultured rat neurons treated with membrane permeant TAT-R1-pep or TAT-scrambled peptides. Total lysates (input) shown on the left. Note decrease in PP2A B55 and C subunits with TAT-R1-pep. Bar graph shows the quantification of co-IP (PP2A-B55/R1 ratio) for TAT-R1-pep condition normalized to the TAT-scrambled peptide. Note significant decrease in PP2A with TAT-R1-pep. Mean ± SEM shown with individual points (*p = 0.0122; t = 4.214, df = 3; one-tailed ratio paired t test). Asterisk for IgG control indicates nonspecific signal with secondary antibody. Arrowhead indicates size for GABABR1. B, Increase in phosphorylation of S783 in GABABR2 subunit after TAT-R1-pep treatment. Blot shows Western with antibody recognizing phosphorylated S783 in R2 (p-S783) for scrambled (TAT-scramb) and TAT-R1-pep conditions following immunoprecipitation of the R1 subunit. Ponceau S shows total protein after IP. C, Bar graph shows the quantification of p-S783 phosphorylation for the TAT-R1-pep condition normalized to the TAT-scrambled peptide. Note significant increase in phosphorylation with TAT-R1-pep (*p = 0.0266; t = 4.157, df = 2, one-tailed ratio paired t test).

Previous work established that PP2A-dependent dephosphorylation of p-S783 controls surface expression of GABABRs in neurons (Terunuma et al., 2010). To examine if exposure to the GABABR1 peptide affects GABABR function, we measured the rate of current rundown, a phenomenon inherent to whole-cell recordings that is caused by the dialysis of the intracellular milieu and results in the rapid internalization of specific membrane proteins (Kuramoto et al., 2007). Application of baclofen (10 μm) leads to stimulation of GABABRs, which in turn activate the GIRK channels. Baclofen activated an outward current that quickly began to rundown over the course of the 15 min recording (Fig. 5Ai). In cells exposed to the scrambled control peptide, the percentage of current remaining at the end of the recording period was 48 ± 4% (N = 7 neurons) (Fig. 5A–C). By contrast, cells exposed to the R1-pep peptide retained 71 ± 5% (N = 7 neurons) of the baseline current (Fig. 5Aii), which was significantly greater than the control peptide (p = 0.0046, two-tailed unpaired t test) (Fig. 5B,C). In the absence of baclofen, the change in the holding current during the 15 min recording was small and not significantly different with each peptide (10.2 ± 2.9 pA for scrambled, vs 11.7 ± 4.9 pA for R1 peptide, p = 0.7958, unpaired t test). This result suggested there was no nonspecific effect of R1 peptide on membrane currents in the cortical neurons. Together, these data support the conclusion that the physical interaction between the GABABR and PP2A plays a direct role in the internalization of GABABRs (Terunuma et al., 2010).

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

R1-pep peptide attenuates rundown of baclofen-activated GIRK currents (IBaclofen) in cultured cortical neurons. A, Representative traces showing baclofen-activated currents recorded from rat cortical neurons at baseline (0 min) and after 15 min for the scrambled peptide (Ai) (QPRTPRHLSQRR, black traces) and PP2A-interfering peptide (Aii) (R1-pep: RQQLRSRRHPPT, magenta traces). Black bars above traces indicate the duration of the baclofen (10 μm) pulse. Holding potential was −50 mV. Inset, Diagram shows inclusion of peptides in the patch pipette and thus directly exposed to the cell interior. B, Plot of the normalized IBaclofen over time for recordings with control peptide (scrambled, black) and R1-pep peptide (magenta). Mean ± SEM is shown (n = 7 cells per condition). C, Dot plot showing the current remaining at 15 min expressed as a percentage of the baclofen-induced current at 0 min for cells exposed to either R1-pep (magenta) or scrambled peptide (black). Bar indicates mean (**p = 0.0046; t = 3.468, df = 12, two-tailed unpaired t test).

Discussion

In this study, we provide evidence that PP2A associates directly with the GABABR through a specific series of amino acids located in the C-terminal domain of the GABABR1 subunit. Disruption of this GABABR1/PP2A interaction appears to reduce dephosphorylation of p-S783 on the GABABR2 subunit, and promote surface expression and functional coupling to GIRK channels in cortical neurons. We discuss the implications of these findings in the context of subcellular signaling and neurological diseases.

PP2A diversity and specificity

Mice injected with psychostimulants exhibit smaller GABABR-activated GIRK currents in VTA GABA neurons, which is expected to increase neuronal excitability of GABA neurons (Padgett et al., 2012; Rifkin et al., 2018). We showed previously that this downregulation of GABABRs was due to PP2A-dependent dephosphorylation of p-S783 and internalization of the GABABR (Padgett et al., 2012). Subsequently, the same PP2A-dependent downregulation of GABABR function was also reported in mPFC and lateral habenula neurons, in response to cocaine and foot shock, respectively (Hearing et al., 2013; Lecca et al., 2016). Similarly, Maeda et al. reported that a PP2A inhibitor suppressed restraint-induced hyperlocomotion in cocaine-sensitized mice (Maeda et al., 2006). Thus, PP2A is emerging as a putative therapeutic target for treating addiction. The challenge, however, is that PP2A is a ubiquitous phosphatase in the body. PP2A is a heterotrimeric complex comprised of three subunits, a catalytic (C), a scaffold (A), and a regulatory (B) subunit (Slupe et al., 2011). Different B subunits provide substrate specificity for PP2A, with the B subunit determining whether PP2A is found in the nucleus, cytosol or attached to the cytoskeleton (Sontag, 2001; Slupe et al., 2011). How the actions of PP2A become selective for a particular signaling pathway is of great interest but poorly understood. Here, we provide new evidence that PP2A associates directly with the GABABR. First, PP2A containing the B55α subunit (see Table 1) coprecipitates with GABABRs and binds to a small region of the GABABR1 C terminal domain. Second, GABABRs expressed either in HEK293 cells or natively in neurons are positioned within a few nm of PP2A, as indicated by a positive PLA signal (Weibrecht et al., 2010; Koos et al., 2014). What promotes the interaction of PP2A with the GABABR? In the striatum, activation of D1Rs leads to increase in cAMP and PKA activation, which in turn phosphorylates PP2A and ultimately leads to dephosphorylation of p-T75 on DARPP-32 (Ahn et al., 2007a,b). The mechanism underlying the increase in PP2A activity with psychostimulants in VTA GABA neurons, however, remains unknown. Experiments suggest elevations in intracellular Ca2+, either through NMDA receptor activation or a Ca2+ ionophore, can regulate the interaction of PP2A with the GABABR. We found that increase in intracellular Ca2+ via the Ca2+ ionophore A23187, leads to a decrease in association of PP2A with the GABABRs (decrease in PLA signal). This would correspond to the initial increase in p-S783 seen with A23187 (Terunuma et al., 2010).

In addition to the PP2A-dependent pathway, GABABR trafficking is also influenced by Ca2+/Calmodulin-dependent protein kinase II (CaMKII). NMDA-dependent internalization of GABABRs also occurs via activation of CaMKII and phosphorylation of serine 867 (S867) in the C terminal domain of GABABR1 subunit (Guetg et al., 2010). PKA-dependent phosphorylation of S892 on GABABR2 promotes stabilization of the receptor on the plasma membrane (Fairfax et al., 2004) and KCTD12 was recently shown to enhance phosphorylation of S892 (Adelfinger et al., 2014). The interplay of regulatory proteins like PP2A and the balance of phosphorylation provide a complex and dynamic mechanism in regulating the surface expression of GABABRs in neurons.

Binding site and complex formation

The PP2A binding site on GABABR1 was narrowed to the region containing 918RQQLRSRRHPPT929, which is adjacent to the coiled-coil domain of GABABR1 that is involved in dimerization with the GABABR2 subunit (White et al., 1998; Kammerer et al., 1999; Margeta-Mitrovic et al., 2000; Burmakina et al., 2014). The finding that PP2A associates directly with GABABRs provides further support for a GABABR signaling complex that contains a multitude of regulatory proteins. In addition, the GABABR can associate with GIRK channels in a signaling complex (Kulik et al., 2006; Fowler et al., 2007; Fernández-Alacid et al., 2009; Ciruela et al., 2010). GIRK channels can also directly associate with trafficking proteins, such as SNX27 (Lunn et al., 2007; Balana et al., 2011). Indeed, a cluster of proteins has been identified that interact directly with, or close to, GABABRs (this study and (Schwenk et al., 2016)). How these protein-protein interactions are regulated and what is the functional impact remain important questions to be addressed in the future. While the evidence is clear that PP2A associates with and regulates GABABRs in the brain, this association could occur either at the plasma membrane or within intracellular compartments. Although we provide evidence that B55 containing PP2A interacts with GABABR1, whether it is the B55 subunit that mediates the direct binding and whether other families of B subunits could mediate PP2A-GABABR1 interaction remain to be tested.

Tat peptide strategy and disease

PP2A inhibitors have been used successfully in animal models to treat anxiety- and depression-like phenotypes (Lecca et al., 2016; Tchenio et al., 2017; O'Connor et al., 2018). In humans, PP2A inhibitors have been used as chemo-sensitizers in treating cancer (O'Connor et al., 2018). For example, LB-100 is a small molecule inhibitor of the PP2A-C subunit and has been tested in Phase I clinical trials for treating solid tumors in combination with Docetaxel (O'Connor et al., 2018). However, there are unwanted side effects with these broad spectrum PP2A inhibitors. Developing a more targeted approach, such as specifically interfering with the association of PP2A with its target as described in our study (i.e., GABABR) could provide a more efficacious and specific strategy for treating human neurological diseases. The ability of TAT peptides to cross cell membranes makes them an ideal tool for this purpose. We showed that a TAT-R1 peptide can significantly reduce dephosphorylation of GABABRs and affect GABAB-GIRK signaling. It will be of interest in the future to determine if slow synaptic transmission mediated by GABABRs and GIRK channels Lüscher et al. (1997) is also affected by antagonizing the interaction of PP2A with GABABRs. TAT peptides have been used to inhibit β-adrenergic receptor activation of If (Saponaro et al., 2018), to disrupt GluA2 association with GAPDH in vivo, protecting against epilepsy-induced neuronal damage (Zhang et al., 2018), and for interfering with NR2B association with Src, decreasing NR2B tyrosine phosphorylation (Ba et al., 2019). Recently, a TAT-modified ω-conotoxin peptide was shown to cross the blood–brain barrier, providing some analgesia (Yu et al., 2019). Thus, TAT peptides offer a promising option for treatment of brain disorders.

Footnotes

  • This work was supported in part by the National Institutes of Health (National Institute on Drug Abuse Grant DA037170 to P.A.S. and S.J.M.; National Institute on Alcohol Abuse and Alcoholism Grant AA018734) to P.A.S.; National Institute of Neurological Disorders and Stroke Grants NS051195, NS056359, NS081735, R21NS080064, and NS087662 to S.J.M.; and National Institute of Mental Health Grant MH097446 to S.J.M.); a 2017 NARSAD Young Investigator Grant (X.L.); and the Yale/NIDA Neuroproteomics Center (Grant P30 DA018343 to S.J.M. and A.C.N.). We thank the Slesinger and Moss laboratories for discussions on the experiments.

  • S.J.M. serves as a consultant for AstraZeneca and SAGE Therapeutics, relationships that are regulated by Tufts University. S.J.M. holds stock in SAGE Therapeutics. The remaining authors declare no competing financial interests.

  • Correspondence should be addressed to Paul Slesinger at paul.slesinger{at}mssm.edu or Stephen Moss at stephen.moss{at}tufts.edu

References

  1. ↵
    1. Adelfinger L,
    2. Turecek R,
    3. Ivankova K,
    4. Jensen AA,
    5. Moss SJ,
    6. Gassmann M,
    7. Bettler B
    (2014) GABAB receptor phosphorylation regulates KCTD12-induced K(+) current desensitization. Biochem Pharmacol 91:369–379. doi:10.1016/j.bcp.2014.07.013 pmid:25065880
    OpenUrlCrossRefPubMed
  2. ↵
    1. Ahn JH,
    2. McAvoy T,
    3. Rakhilin SV,
    4. Nishi A,
    5. Greengard P,
    6. Nairn AC
    (2007a) Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56 subunit. Proc Natl Acad Sci U S A 104:2979–2984. doi:10.1073/pnas.0611532104 pmid:17301223
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Ahn JH,
    2. Sung JY,
    3. McAvoy T,
    4. Nishi A,
    5. Janssens V,
    6. Goris J,
    7. Greengard P,
    8. Nairn AC
    (2007b) The B′′/PR72 subunit mediates Ca2+-dependent dephosphorylation of DARPP-32 by protein phosphatase 2A. Proc Natl Acad Sci U S A 104:9876–9881. doi:10.1073/pnas.0703589104 pmid:17535922
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Atwood BK,
    2. Lopez J,
    3. Wager-Miller J,
    4. Mackie K,
    5. Straiker A
    (2011) Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis. BMC Genomics 12:14. doi:10.1186/1471-2164-12-14 pmid:21214938
    OpenUrlCrossRefPubMed
  5. ↵
    1. Ba M,
    2. Yu G,
    3. Yang H,
    4. Wang Y,
    5. Yu L,
    6. Kong M
    (2019) Tat-src reduced NR2B tyrosine phosphorylation and its interaction with NR2B in levodopa-induced dyskinetic rats model. Behav Brain Res 356:41–45. doi:10.1016/j.bbr.2018.08.013 pmid:30130562
    OpenUrlCrossRefPubMed
  6. ↵
    1. Balana B,
    2. Maslennikov I,
    3. Kwiatkowski W,
    4. Stern KM,
    5. Bahima L,
    6. Choe S,
    7. Slesinger PA
    (2011) Mechanism underlying selective regulation of G protein-gated inwardly rectifying potassium channels by the psychostimulant-sensitive sorting nexin 27. Proc Natl Acad Sci U S A 108:5831–5836. doi:10.1073/pnas.1018645108 pmid:21422294
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Benke D,
    2. Zemoura K,
    3. Maier PJ
    (2012) Modulation of cell surface GABA(B) receptors by desensitization, trafficking and regulated degradation. World J Biol Chem 3:61–72. doi:10.4331/wjbc.v3.i4.61 pmid:22558486
    OpenUrlCrossRefPubMed
  8. ↵
    1. Bowery NG
    (2006) GABAB receptor: a site of therapeutic benefit. Curr Opin Pharmacol 6:37–43. doi:10.1016/j.coph.2005.10.002 pmid:16361115
    OpenUrlCrossRefPubMed
  9. ↵
    1. Burmakina S,
    2. Geng Y,
    3. Chen Y,
    4. Fan QR
    (2014) Heterodimeric coiled-coil interactions of human GABAB receptor. Proc Natl Acad Sci U S A 111:6958–6963. doi:10.1073/pnas.1400081111 pmid:24778228
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Ciruela F,
    2. Fernández-Dueñas V,
    3. Sahlholm K,
    4. Fernández-Alacid L,
    5. Nicolau JC,
    6. Watanabe M,
    7. Luján R
    (2010) Evidence for oligomerization between GABAB receptors and GIRK channels containing the GIRK1 and GIRK3 subunits. Eur J Neurosci 32:1265–1277. doi:10.1111/j.1460-9568.2010.07356.x pmid:20846323
    OpenUrlCrossRefPubMed
  11. ↵
    1. Couve A,
    2. Filippov AK,
    3. Connolly CN,
    4. Bettler B,
    5. Brown DA,
    6. Moss SJ
    (1998) Intracellular retention of recombinant GABAB receptors. J Biol Chem 273:26361–26367. doi:10.1074/jbc.273.41.26361 pmid:9756866
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Couve A,
    2. Kittler JT,
    3. Uren JM,
    4. Calver AR,
    5. Pangalos MN,
    6. Walsh FS,
    7. Moss SJ
    (2001) Association of GABA(B) receptors and members of the 14–3-3 family of signaling proteins. Mol Cell Neurosci 17:317–328. doi:10.1006/mcne.2000.0938 pmid:11178869
    OpenUrlCrossRefPubMed
  13. ↵
    1. Couve A,
    2. Thomas P,
    3. Calver AR,
    4. Hirst WD,
    5. Pangalos MN,
    6. Walsh FS,
    7. Smart TG,
    8. Moss SJ
    (2002) Cyclic AMP-dependent protein kinase phosphorylation facilitates GABA(B) receptor-effector coupling. Nat Neurosci 5:415–424. doi:10.1038/nn833 pmid:11976702
    OpenUrlCrossRefPubMed
  14. ↵
    1. Fairfax BP,
    2. Pitcher JA,
    3. Scott MG,
    4. Calver AR,
    5. Pangalos MN,
    6. Moss SJ,
    7. Couve A
    (2004) Phosphorylation and chronic agonist treatment atypically modulate GABAB receptor cell surface stability. J Biol Chem 279:12565–12573. doi:10.1074/jbc.M311389200 pmid:14707142
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Fernández-Alacid L,
    2. Aguado C,
    3. Ciruela F,
    4. Martín R,
    5. Colón J,
    6. Cabañero MJ,
    7. Gassmann M,
    8. Watanabe M,
    9. Shigemoto R,
    10. Wickman K,
    11. Bettler B,
    12. Sánchez-Prieto J,
    13. Luján R
    (2009) Subcellular compartment-specific molecular diversity of pre- and post-synaptic GABA-activated GIRK channels in Purkinje cells. J Neurochem 110:1363–1376. doi:10.1111/j.1471-4159.2009.06229.x pmid:19558451
    OpenUrlCrossRefPubMed
  16. ↵
    1. Fowler CE,
    2. Aryal P,
    3. Suen KF,
    4. Slesinger PA
    (2007) Evidence for association of GABAB receptors with Kir3 channels and RGS4 proteins. J Physiol 580:51–65. doi:10.1113/jphysiol.2006.123216 pmid:17185339
    OpenUrlCrossRefPubMed
  17. ↵
    1. Galvez T,
    2. Prezeau L,
    3. Milioti G,
    4. Franek M,
    5. Joly C,
    6. Froestl W,
    7. Bettler B,
    8. Bertrand HO,
    9. Blahos J,
    10. Pin JP
    (2000) Mapping the agonist-binding site of GABAB type 1 subunit sheds light on the activation process of GABAB receptors. J Biol Chem 275:41166–41174. doi:10.1074/jbc.M007848200 pmid:10986293
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Galvez T,
    2. Duthey B,
    3. Kniazeff J,
    4. Blahos J,
    5. Rovelli G,
    6. Bettler B,
    7. Prézeau L,
    8. Pin JP
    (2001) Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function. EMBO J 20:2152–2159. doi:10.1093/emboj/20.9.2152 pmid:11331581
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Green M,
    2. Loewenstein PM
    (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55:1179–1188. doi:10.1016/0092-8674(88)90262-0 pmid:2849509
    OpenUrlCrossRefPubMed
  20. ↵
    1. Guetg N,
    2. Abdel Aziz S,
    3. Holbro N,
    4. Turecek R,
    5. Rose T,
    6. Seddik R,
    7. Gassmann M,
    8. Moes S,
    9. Jenoe P,
    10. Oertner TG,
    11. Casanova E,
    12. Bettler B
    (2010) NMDA receptor-dependent GABAB receptor internalization via CaMKII phosphorylation of serine 867 in GABAB1. Proc Natl Acad Sci U S A 107:13924–13929. doi:10.1073/pnas.1000909107 pmid:20643921
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Hearing M,
    2. Kotecki L,
    3. Marron Fernández de Velasco E,
    4. Fajardo-Serrano A,
    5. Chung HJ,
    6. Luján R,
    7. Wickman K
    (2013) Repeated cocaine weakens GABA(B)-girk signaling in layer 5/6 pyramidal neurons in the prelimbic cortex. Neuron 80:159–170. doi:10.1016/j.neuron.2013.07.019 pmid:24094109
    OpenUrlCrossRefPubMed
  22. ↵
    1. Kammerer RA,
    2. Frank S,
    3. Schulthess T,
    4. Landwehr R,
    5. Lustig A,
    6. Engel J
    (1999) Heterodimerization of a functional GABAB receptor is mediated by parallel coiled-coil alpha-helices. Biochemistry 38:13263–13269. doi:10.1021/bi991018t pmid:10529199
    OpenUrlCrossRefPubMed
  23. ↵
    1. Koos B,
    2. Andersson L,
    3. Clausson CM,
    4. Grannas K,
    5. Klaesson A,
    6. Cane G,
    7. Söderberg O
    (2014) Analysis of protein interactions in situ by proximity ligation assays. Curr Top Microbiol Immunol 377:111–126. doi:10.1007/82_2013_334 pmid:23921974
    OpenUrlCrossRefPubMed
  24. ↵
    1. Kulik A,
    2. Vida I,
    3. Fukazawa Y,
    4. Guetg N,
    5. Kasugai Y,
    6. Marker CL,
    7. Rigato F,
    8. Bettler B,
    9. Wickman K,
    10. Frotscher M,
    11. Shigemoto R
    (2006) Compartment-dependent colocalization of Kir3.2-containing K+ channels and GABAB receptors in hippocampal pyramidal vells. J Neurosci 26:4289–4297. doi:10.1523/JNEUROSCI.4178-05.2006 pmid:16624949
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Kuramoto N,
    2. Wilkins ME,
    3. Fairfax BP,
    4. Revilla-Sanchez R,
    5. Terunuma M,
    6. Tamaki K,
    7. Iemata M,
    8. Warren N,
    9. Couve A,
    10. Calver A,
    11. Horvath Z,
    12. Freeman K,
    13. Carling D,
    14. Huang L,
    15. Gonzales C,
    16. Cooper E,
    17. Smart TG,
    18. Pangalos MN,
    19. Moss SJ
    (2007) Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase. Neuron 53:233–247. doi:10.1016/j.neuron.2006.12.015 pmid:17224405
    OpenUrlCrossRefPubMed
  26. ↵
    1. Lecca S,
    2. Pelosi A,
    3. Tchenio A,
    4. Moutkine I,
    5. Lujan R,
    6. Hervé D,
    7. Mameli M
    (2016) Rescue of GABAB and GIRK function in the lateral habenula by protein phosphatase 2A inhibition ameliorates depression-like phenotypes in mice. Nat Med 22:254–261. doi:10.1038/nm.4037 pmid:26808347
    OpenUrlCrossRefPubMed
  27. ↵
    1. Lunn ML,
    2. Nassirpour R,
    3. Arrabit C,
    4. Tan J,
    5. McLeod I,
    6. Arias CM,
    7. Sawchenko PE,
    8. Yates JR 3rd.,
    9. Slesinger PA
    (2007) A unique sorting nexin regulates trafficking of potassium channels via a PDZ domain interaction. Nat Neurosci 10:1249–1259. doi:10.1038/nn1953 pmid:17828261
    OpenUrlCrossRefPubMed
  28. ↵
    1. Lüscher C,
    2. Jan LY,
    3. Stoffel M,
    4. Malenka RC,
    5. Nicoll RA
    (1997) G-protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic, but not presynaptic transmitter actions in hippocampal neurons. Neuron 19:687–695.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Maeda T,
    2. Yoshimatsu T,
    3. Hamabe W,
    4. Fukazawa Y,
    5. Kumamoto K,
    6. Ozaki M,
    7. Kishioka S
    (2006) Involvement of serine/threonine protein phosphatases sensitive to okadaic acid in restraint stress-induced hyperlocomotion in cocaine-sensitized mice. Br J Pharmacol 148:405–412. doi:10.1038/sj.bjp.0706769 pmid:16682959
    OpenUrlCrossRefPubMed
  30. ↵
    1. Margeta-Mitrovic M,
    2. Jan YN,
    3. Jan LY
    (2000) A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27:97–106. doi:10.1016/S0896-6273(00)00012-X pmid:10939334
    OpenUrlCrossRefPubMed
  31. ↵
    1. Munoz MB,
    2. Padgett CL,
    3. Rifkin R,
    4. Terunuma M,
    5. Wickman K,
    6. Contet C,
    7. Moss SJ,
    8. Slesinger PA
    (2016) A role for the GIRK3 subunit in methamphetamine-induced attenuation of GABAB receptor-activated GIRK currents in VTA dopamine neurons. J Neurosci 36:3106–3114. doi:10.1523/JNEUROSCI.1327-15.2016 pmid:26985023
    OpenUrlAbstract/FREE Full Text
  32. ↵
    1. Nakamura Y,
    2. Morrow DH,
    3. Modgil A,
    4. Huyghe D,
    5. Deeb TZ,
    6. Lumb MJ,
    7. Davies PA,
    8. Moss SJ
    (2016) Proteomic characterization of inhibitory synapses using a novel pHluorin-tagged gamma-aminobutyric acid receptor, type A (GABAA), alpha2 subunit knock-in mouse. J Biol Chem 291:12394–12407. doi:10.1074/jbc.M116.724443 pmid:27044742
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. O'Connor CM,
    2. Perl A,
    3. Leonard D,
    4. Sangodkar J,
    5. Narla G
    (2018) Therapeutic targeting of PP2A. Int J Biochem Cell Biol 96:182–193. doi:10.1016/j.biocel.2017.10.008 pmid:29107183
    OpenUrlCrossRefPubMed
  34. ↵
    1. Padgett CL,
    2. Lalive AL,
    3. Tan KR,
    4. Terunuma M,
    5. Munoz MB,
    6. Pangalos MN,
    7. Martínez-Hernández J,
    8. Watanabe M,
    9. Moss SJ,
    10. Luján R,
    11. Lüscher C,
    12. Slesinger PA
    (2012) Methamphetamine-evoked depression of GABA(B) receptor signaling in GABA neurons of the VTA. Neuron 73:978–989. doi:10.1016/j.neuron.2011.12.031 pmid:22405207
    OpenUrlCrossRefPubMed
  35. ↵
    1. Pagano A,
    2. Rovelli G,
    3. Mosbacher J,
    4. Lohmann T,
    5. Duthey B,
    6. Stauffer D,
    7. Ristig D,
    8. Schuler V,
    9. Meigel I,
    10. Lampert C,
    11. Stein T,
    12. Prezeau L,
    13. Blahos J,
    14. Pin J,
    15. Froestl W,
    16. Kuhn R,
    17. Heid J,
    18. Kaupmann K,
    19. Bettler B
    (2001) C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors. J Neurosci 21:1189–1202. doi:10.1523/JNEUROSCI.21-04-01189.2001 pmid:11160389
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Raveh A,
    2. Turecek R,
    3. Bettler B
    (2015) Mechanisms of fast desensitization of GABA(B) receptor-gated currents. Adv Pharmacol 73:145–165. doi:10.1016/bs.apha.2014.11.004 pmid:25637440
    OpenUrlCrossRefPubMed
  37. ↵
    1. Rifkin RA,
    2. Huyghe D,
    3. Li X,
    4. Parakala M,
    5. Aisenberg E,
    6. Moss SJ,
    7. Slesinger PA
    (2018) GIRK currents in VTA dopamine neurons control the sensitivity of mice to cocaine-induced locomotor sensitization. Proc Natl Acad Sci U S A 115:E9479–E9488. doi:10.1073/pnas.1807788115 pmid:30228121
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. Saponaro A,
    2. Cantini F,
    3. Porro A,
    4. Bucchi A,
    5. DiFrancesco D,
    6. Maione V,
    7. Donadoni C,
    8. Introini B,
    9. Mesirca P,
    10. Mangoni ME,
    11. Thiel G,
    12. Banci L,
    13. Santoro B,
    14. Moroni A
    (2018) A synthetic peptide that prevents camp regulation in mammalian hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. Elife 7:e35753. doi:10.7554/eLife.35753 pmid:29923826
    OpenUrlCrossRefPubMed
  39. ↵
    1. Schwenk J,
    2. Pérez-Garci E,
    3. Schneider A,
    4. Kollewe A,
    5. Gauthier-Kemper A,
    6. Fritzius T,
    7. Raveh A,
    8. Dinamarca MC,
    9. Hanuschkin A,
    10. Bildl W,
    11. Klingauf J,
    12. Gassmann M,
    13. Schulte U,
    14. Bettler B,
    15. Fakler B
    (2016) Modular composition and dynamics of native GABAB receptors identified by high-resolution proteomics. Nat Neurosci 19:233–242. doi:10.1038/nn.4198 pmid:26691831
    OpenUrlCrossRefPubMed
  40. ↵
    1. Slupe AM,
    2. Merrill RA,
    3. Strack S
    (2011) Determinants for substrate specificity of protein phosphatase 2A. Enzyme Res 2011:398751. doi:10.4061/2011/398751 pmid:21755039
    OpenUrlCrossRefPubMed
  41. ↵
    1. Sontag E
    (2001) Protein phosphatase 2A: the trojan horse of cellular signaling. Cell Signal 13:7–16. doi:10.1016/S0898-6568(00)00123-6 pmid:11257442
    OpenUrlCrossRefPubMed
  42. ↵
    1. Tchenio A,
    2. Lecca S,
    3. Valentinova K,
    4. Mameli M
    (2017) Limiting habenular hyperactivity ameliorates maternal separation-driven depressive-like symptoms. Nat Commun 8:1135. doi:10.1038/s41467-017-01192-1 pmid:29074844
    OpenUrlCrossRefPubMed
  43. ↵
    1. Terunuma M,
    2. Vargas KJ,
    3. Wilkins ME,
    4. Ramírez OA,
    5. Jaureguiberry-Bravo M,
    6. Pangalos MN,
    7. Smart TG,
    8. Moss SJ,
    9. Couve A
    (2010) Prolonged activation of NMDA receptors promotes dephosphorylation and alters postendocytic sorting of GABAB receptors. Proc Natl Acad Sci U S A 107:13918–13923. doi:10.1073/pnas.1000853107 pmid:20643948
    OpenUrlAbstract/FREE Full Text
  44. ↵
    1. Terunuma M,
    2. Revilla-Sanchez R,
    3. Quadros IM,
    4. Deng Q,
    5. Deeb TZ,
    6. Lumb M,
    7. Sicinski P,
    8. Haydon PG,
    9. Pangalos MN,
    10. Moss SJ
    (2014) Postsynaptic GABAB receptor activity regulates excitatory neuronal architecture and spatial memory. J Neurosci 34:804–816. doi:10.1523/JNEUROSCI.3320-13.2013 pmid:24431439
    OpenUrlAbstract/FREE Full Text
  45. ↵
    1. Vargas KJ,
    2. Terunuma M,
    3. Tello JA,
    4. Pangalos MN,
    5. Moss SJ,
    6. Couve A
    (2008) The availability of surface GABA B receptors is independent of gamma-aminobutyric acid but controlled by glutamate in central neurons. J Biol Chem 283:24641–24648. doi:10.1074/jbc.M802419200 pmid:18579521
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Weibrecht I,
    2. Leuchowius KJ,
    3. Clausson CM,
    4. Conze T,
    5. Jarvius M,
    6. Howell WM,
    7. Kamali-Moghaddam M,
    8. Söderberg O
    (2010) Proximity ligation assays: a recent addition to the proteomics toolbox. Expert Rev Proteomics 7:401–409. doi:10.1586/epr.10.10 pmid:20536310
    OpenUrlCrossRefPubMed
  47. ↵
    1. White JH,
    2. Wise A,
    3. Main MJ,
    4. Green A,
    5. Fraser NJ,
    6. Disney GH,
    7. Barnes AA,
    8. Emson P,
    9. Foord SM,
    10. Marshall FH
    (1998) Heterodimerization is required for the formation of a functional GABAB receptor. Nature 396:679–682. doi:10.1038/25354 pmid:9872316
    OpenUrlCrossRefPubMed
  48. ↵
    1. Yu S,
    2. Li Y,
    3. Chen J,
    4. Zhang Y,
    5. Tao X,
    6. Dai Q,
    7. Wang Y,
    8. Li S,
    9. Dong M
    (2019) TAT-modified ω-conotoxin MVIIA for crossing the blood–brain barrier. Mar Drugs 17:E286. doi:10.3390/md17050286 pmid:31083641
    OpenUrlCrossRefPubMed
  49. ↵
    1. Zemoura K,
    2. Balakrishnan K,
    3. Grampp T,
    4. Benke D
    (2019) Ca(2+)/Calmodulin-dependent protein kinase II (CaMKII) beta-dependent phosphorylation of GABAB1 triggers lysosomal degradation of GABAB receptors via mind bomb-2 (MIB2)-mediated lys-63-linked ubiquitination. Mol Neurobiol 56:1293–1309. doi:10.1007/s12035-018-1142-5 pmid:29881949
    OpenUrlCrossRefPubMed
  50. ↵
    1. Zhang J,
    2. Qiao N,
    3. Ding X,
    4. Wang J
    (2018) Disruption of the GluA2/GAPDH complex using TAT-GluA2 NT1–3-2 peptide protects against AMPAR-mediated excitotoxicity after epilepsy. Neuroreport 29:432–439. doi:10.1097/WNR.0000000000000996 pmid:29489588
    OpenUrlCrossRefPubMed
Back to top

In this issue

The Journal of Neuroscience: 40 (14)
Journal of Neuroscience
Vol. 40, Issue 14
1 Apr 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Direct Interaction of PP2A Phosphatase with GABAB Receptors Alters Functional Signaling
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Direct Interaction of PP2A Phosphatase with GABAB Receptors Alters Functional Signaling
Xiaofan Li, Miho Terunuma, Tarek G. Deeb, Shari Wiseman, Menelas N. Pangalos, Angus C. Nairn, Stephen J. Moss, Paul A. Slesinger
Journal of Neuroscience 1 April 2020, 40 (14) 2808-2816; DOI: 10.1523/JNEUROSCI.2654-19.2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Direct Interaction of PP2A Phosphatase with GABAB Receptors Alters Functional Signaling
Xiaofan Li, Miho Terunuma, Tarek G. Deeb, Shari Wiseman, Menelas N. Pangalos, Angus C. Nairn, Stephen J. Moss, Paul A. Slesinger
Journal of Neuroscience 1 April 2020, 40 (14) 2808-2816; DOI: 10.1523/JNEUROSCI.2654-19.2020
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • GABA(B)
  • GIRK
  • inhibition
  • phosphatase
  • PLA
  • trafficking

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Articles

  • Downregulating PTBP1 fails to convert astrocytes into hippocampal neurons and to alleviate symptoms in Alzheimer’s mouse models
  • Drosophila Homolog of the Human Carpenter Syndrome Linked Gene, MEGF8, is Required for Synapse Development and Function
  • Dopamine Modulates Adaptive Forgetting in Medial Prefrontal Cortex
Show more Research Articles

Cellular/Molecular

  • Drosophila Homolog of the Human Carpenter Syndrome Linked Gene, MEGF8, is Required for Synapse Development and Function
  • Dual Leucine Zipper Kinase Regulates Dscam Expression through a Noncanonical Function of the Cytoplasmic Poly(A)-Binding Protein
  • Meclizine and Metabotropic Glutamate Receptor Agonists Attenuate Severe Pain and Ca2+ Activity of Primary Sensory Neurons in Chemotherapy-Induced Peripheral Neuropathy
Show more Cellular/Molecular
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2022 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.